Hormos Medical Oy Ltd.
Records under this name other than patents Hormos Medical Oy Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Hormos Medical Oy Ltd.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,642,079 | Solid Formulations of Ospemifene Formerly held In force · High confidence | In force | High confidence | |
| US 8,236,861 | Method for Enhancing the Bioavailability of Ospemifene Formerly held Term ended Term ended Aug 11, 2026 · High confidence | Term ended | Term ended Aug 11, 2026 | High confidence |
| US 6,245,819 | Method for the treatment of vaginal dryness and sexual dysfunction in women during or after the menopause Formerly held Term ended Term ended Jul 21, 2025 · USPTO record | Term ended | Term ended Jul 21, 2025 | USPTO record |
| US RE47,316 | Oral formulations of ospemifene Formerly held Term ended Term ended May 3, 2025 · USPTO record | Term ended | Term ended May 3, 2025 | USPTO record |
| US 8,470,890 | Method for Enhancing the Bioavailability of Ospemifene Formerly held Term ended Term ended Feb 13, 2024 · High confidence | Term ended | Term ended Feb 13, 2024 | High confidence |
| US 8,772,353 | Method for Enhancing the Bioavalability of Ospemifene Formerly held Term ended Ended no later than Feb 13, 2024 · Medium confidence | Term ended | Ended no later than Feb 13, 2024 | Medium confidence |
| US 9,855,224 | Method for Enhancing the Bioavailability of Ospemifene Formerly held Term ended Term ended Feb 13, 2024 · Medium confidence | Term ended | Term ended Feb 13, 2024 | Medium confidence |
| US 9,241,915 | Method for Enhancing the Bioavailability of Ospemifene Formerly held Lapsed on the fee record Ended Jan 26, 2024 · Medium confidence | Lapsed on the fee record | Ended Jan 26, 2024 | Medium confidence |
| US 9,566,252 | Method for the alleviation of dyspareunia in women Formerly held Term ended Term ended Nov 2, 2022 · USPTO record | Term ended | Term ended Nov 2, 2022 | USPTO record |
| US 6,984,665 | Methods for the Inhibition of Atrophy or for Treatment or Prevention of Atrophy-Related Symptoms in Women Formerly held Term ended Term ended Jul 10, 2021 · Medium confidence | Term ended | Term ended Jul 10, 2021 | Medium confidence |